Skip to main content

META Announces Third Quarter and YTD 2021 Results

HALIFAX, NS / ACCESSWIRE / November 15, 2021 / Meta Materials Inc. (the "Company" or "META®") (NASDAQ:MMAT, FSE:MMAT) a developer of high-performance functional materials and nanocomposites, today announced third quarter and YTD 2021 results. Please visit the Investors section of our website to view the Q3 2021 Shareholder Letter.

The interim financial statements and the associated management discussion and analysis for the quarter ended September 30, 2021 are available on the Investors section of our website as well as on or on the SEC EDGAR website at

In Q3 2021, total revenue grew 189%, to $572,612, compared to $198,175 in Q3 2020. For the nine months YTD 2021, total revenue increased by 111%, to $1,793,235, versus $848,858 in the first nine months of 2020. The Q3 2021 net loss was $11,425,248, $0.04 per share on 280,080,786 weighted average shares, compared to a net loss of $2,581,204, $0.02 per share on 155,913,202 weighted average shares in Q3 2020. For the nine months YTD 2021, the net loss was $61,467,070 (which includes a one-time, non-cash loss of $40,540,091 on financial instruments), $0.28 per share on 216,135,190 weighted average shares, compared to a loss of $5,815,233, $0.04 per share on 131,557,607 weighted average shares in the first nine months of 2020.

Net cash used in operating activities during the nine months YTD 2021 was $15,584,000, compared to $5,903,523 in the first nine months of 2020. Capital expenditures for purchases of property, plant, and equipment and intangible assets totaled $6,390,932. As of September 30, 2021, cash and cash equivalents totaled $140,796,052, and common shares outstanding were 281,200,905. Subsequent to quarter end, the Company used $72.1MM in cash to complete the acquisition of Nanotech Security Corp.

About Meta Materials Inc.

META® delivers previously unachievable performance, across a range of applications, by inventing, designing, developing, and manufacturing sustainable, highly functional materials. Our extensive technology platform enables leading global brands to deliver breakthrough products to their customers in consumer electronics, 5G communications, health and wellness, aerospace, automotive, and clean energy. Our nano-optic technology provides anti-counterfeiting security features for government documents and currencies and authentication for brands. Our achievements have been widely recognized, including being named a Lux Research Innovator of the Year in 2021. Learn more at


As of
September 30, 2021
As of
December 31, 2020


Current assets

Cash and cash equivalents
$140,796,052 $1,395,683
Restricted cash
421,817 -
Grants receivable
285,063 327,868
Accounts receivable
96,848 22,833
358,964 463,382
Prepaid expenses and other current assets
3,262,595 514,204
Assets held for sale
73,650,140 -
Due from related parties
64,708 -
Total current assets
218,936,187 2,723,970
Intangible assets, net
4,642,904 4,476,614
Property, plant and equipment, net
7,525,989 2,761,171
Operating lease right-of-use assets
4,775,130 270,581
218,828,518 -
Total assets
$454,708,728 $10,232,336

Liabilities and stockholders' equity (deficit)
Current liabilities
Trade and other payables
6,556,665 2,940,452
Due to related party
- 245,467
Current portion of long-term debt
532,346 290,544
Current portion of deferred revenue
1,186,885 1,239,927
Current portion of deferred government assistance
842,425 779,578
Preferred stock liability
Current portion of operating lease liabilities
330,867 150,802
Asset retirement obligations
Unsecured convertible promissory notes
- 1,203,235
Secured convertible debentures
- 5,545,470
Total current liabilities
87,377,479 12,395,475
Deferred revenue
637,559 804,143
Deferred government assistance
38,869 146,510
Deferred tax liability
131,907 318,054
Unsecured convertible debentures
- 1,825,389
Long-term operating lease liabilities
2,423,123 119,779
Funding obligation
868,169 776,884
Long-term debt
2,698,515 2,743,504
Total liabilities
94,175,621 19,129,738

Stockholders' equity (deficit)
Common stock - $0.001 par value; 1,000,000,000 shares authorized, 281,200,905 shares issued and outstanding at September 30, 2021, and $Nil par value; unlimited shares authorized, 154,163,975 shares issued and outstanding at December 31, 2020
259,384 132,347
Additional paid-in capital
459,129,666 29,021,974
Accumulated other comprehensive income (loss)
7,970 (654,880)
Accumulated deficit
(98,863,913) (37,396,843)
Total stockholders' equity (deficit)
360,533,107 (8,897,402)
Total liabilities and stockholders' equity (deficit)
$454,708,728 $10,232,336


Three months ended
September 30,
Nine months ended
September 30,

2021 2020 2021 2020


Product sales
297,431 982 321,431 2,904
Development revenue
275,181 197,193 1,471,804 845,954
Total Revenue
572,612 198,175 1,793,235 848,858
Cost of goods sold
145,103 935 146,209 3,095
Gross Profit
427,509 197,240 1,647,026 845,763
Operating Expenses
Selling & Marketing
427,004 196,276 1,122,469 520,804
General & Administrative
9,776,850 1,463,255 16,217,012 4,620,907
Research & Development
1,816,547 1,043,915 5,229,456 2,936,516
Total operating expenses
12,020,401 2,703,446 22,568,937 8,078,227
Other income (expense)
Interest expense, net
(215,116) (376,776) (1,093,833) (893,001)
(Loss) Gain on foreign exchange, net
(440,157) (175,514) (770,542) 81,159
(Loss) Gain on financial instruments, net
- (118,455) (40,540,091) 1,167,310
Other income, net
739,260 562,443 1,673,124 974,112
Total other income (expenses)
83,987 (108,302) (40,731,342) 1,329,580
Loss before income taxes
(11,508,905) (2,614,508) (61,653,253) (5,902,884)
Income tax recovery
83,657 33,304 186,183 87,651
Net loss
(11,425,248) (2,581,204) (61,467,070) (5,815,233)
Other Comprehensive Income (Loss) net of tax
Foreign currency translation gain (loss)
(125,976) 167,941 (17,328) 8,693
Fair value gain (loss) on changes of own credit risk
- (223,221) 680,178 (588,429)
Total Other Comprehensive Income (Loss)
(125,976) (55,280) 662,850 (579,736)
Comprehensive loss
(11,551,224) (2,636,484) (60,804,220) (6,394,969)
Basic and diluted loss per share
(0.04) (0.02) (0.28) (0.04)
Weighted average number of shares outstanding - basic and diluted
280,080,786 155,913,202 216,135,190 131,557,607


Nine months ended

September 30, 2021 September 30, 2020

$ $

Cash flows from operating activities:
Net loss
(61,467,070) (5,815,233)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash finance income
- (14,002)
Non-cash interest expense
904,749 611,808
Non-cash lease expense
256,785 -
Deferred income tax
(186,183) (87,651)
Depreciation and amortization
1,798,607 1,768,261
Unrealized foreign currency exchange loss (gain)
279,805 (146,433)
Loss (gain) on financial instruments, net
40,540,091 (1,167,310)
Change in deferred revenue
(239,057) (380,494)
Non-cash government assistance
(508,730) (274,632)
Loss on debt settlement
19,253 -
Stock-based compensation
855,989 1,114,814
Non-cash consulting expense
3,926,628 43,673
Changes in operating assets and liabilities
(1,764,867) (1,556,324)
Net cash used in operating activities
(15,584,000) (5,903,523)
Cash flows from investing activities
Purchases of intangible assets
(838,664) (60,716)
Purchases of property, plant and equipment
(5,552,268) (651,651)
Proceeds from reverse takeover
146,954,733 3,072,136
Net cash provided by investing activities
140,563,801 2,359,769
Cash flows from financing activities
Proceeds from long-term debt
1,127,151 25,783
Repayments of long-term debt
(938,496) (190,633)
Proceeds from government grants
223,384 198,286
Proceeds from unsecured promissory notes
13,963,386 502,987
Proceeds from secured convertible debentures
- 3,630,019
Proceeds from unsecured convertible debentures
- 693,784
Proceeds from issuance of common stock and warrants, net
- 598,546
Proceeds from stock option exercises
374,652 -
Proceeds from warrants exercises
93,993 -
Proceeds from broker warrants exercises
16,255 -
Net cash provided by financing activities
14,860,325 5,458,772

Net increase in cash, cash equivalents and restricted cash
139,840,126 1,915,018
Cash, cash equivalents and restricted cash at beginning of the period
1,395,683 407,061
Effects of exchange rate changes on cash, cash equivalents and restricted cash
(17,940) 83,582
Cash, cash equivalents and restricted cash at end of the period
141,217,869 2,405,661

Supplemental cash flow information
Accrued purchases of property, equipment, and patents
799,305 225,357
Right-of-use assets obtained in exchange for lease liabilities
892,003 -
Right-of-use assets and prepaid expenses recognized in exchange for common stock
2,149,381 -
Settlement of liabilities in common stock
52,063,432 -
Interest paid on debt
64,528 114,040

Forward-Looking Information

This press release includes forward-looking information or statements within the meaning of Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, regarding the Company, which may include, but are not limited to, statements with respect to the business strategies, product development, expansion plans and operational activities of the Company . Often but not always, forward-looking information can be identified by the use of words such as "pursuing", "potential", "predicts", "projects", "seeks", "plans", "expect", "intends", "anticipated", "believes" or variations (including negative variations) of such words and phrases, or statements that certain actions, events or results "may", "could", "should", "would" or "will" be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of the Company and are based on assumptions and subject to risks and uncertainties. Although the management of the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, the capabilities of our facilities and the expansion thereof, research and development projects of the Company, the market potential of the products of the Company , the market position of the Company, the scalability of the Company's production ability, capacity for new customer engagements, material selection programs timeframes, the ability to reduce production costs, enhance metamaterials manufacturing capabilities and extend market reach into new applications and industries, the ability to accelerate commercialization plans, the possibility of new customer contracts, the continued engagement of our employees, the technology industry, market strategic and operational activities, and management's ability to manage and to operate the business. More details about these and other risks that may impact the Company's businesses are described under the heading "Forward-Looking Information" and under the heading "Risk Factors" in the Company's Form 10-Q filed with the SEC on November 15, 2021, in the Company's Form 10-K filed with the SEC on March 18, 2021, and in subsequent filings made by Meta Materials with the SEC, which are available on SEC's website at Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except to the extent required by law.

Investor Contact

Mark Komonoski
Senior Vice President
Integrous Communications
Phone: 1-877-255-8483

Media Inquiries

Rob Stone
Vice President, Corporate Development and Communications
Meta Materials Inc.

SOURCE: Meta Materials Inc.

View source version on

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.